{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T20:03:44Z","timestamp":1760385824276,"version":"3.37.3"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["20HA2003"],"award-info":[{"award-number":["20HA2003"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19fk0108061"],"award-info":[{"award-number":["JP19fk0108061"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0240655","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T17:33:50Z","timestamp":1603388030000},"page":"e0240655","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Improved penicillin susceptibility of Streptococcus pneumoniae and increased penicillin consumption in Japan, 2013\u201318"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8504-1244","authenticated-orcid":true,"given":"Shinya","family":"Tsuzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Yahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keigo","family":"Shibayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyuki","family":"Sugai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Ohmagari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"unstructured":"World Health Organization. WHO | Global action plan on antimicrobial resistance. [cited 5 Feb 2019]. http:\/\/www.who.int\/antimicrobial-resistance\/publications\/global-action-plan\/en\/.","key":"pone.0240655.ref001"},{"unstructured":"European Commission. A European one health action plan against antimicrobial resitance (AMR). 2017 [cited 13 Mar 2019]. https:\/\/ec.europa.eu\/health\/amr\/sites\/amr\/files\/amr_action_plan_2017_en.pdf.","key":"pone.0240655.ref002"},{"key":"pone.0240655.ref003","doi-asserted-by":"crossref","first-page":"i88","DOI":"10.1093\/jac\/dkaa086","article-title":"Results from the Survey of Antibiotic Resistance (SOAR) 2015\u201317 in Turkey: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic\/pharmacodynamic (PK\/PD) breakpoints","volume":"75","author":"D Torumkuney","year":"2020","journal-title":"J Antimicrob Chemother"},{"unstructured":"CDC. The biggest antibiotic-resistant threats in the U.S. In: Centers for Disease Control and Prevention [Internet]. 7 May 2019 [cited 30 Jun 2019]. https:\/\/www.cdc.gov\/drugresistance\/biggest_threats.html.","key":"pone.0240655.ref004"},{"unstructured":"Public Health England. English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Report 2018. 2018; 163.","key":"pone.0240655.ref005"},{"key":"pone.0240655.ref006","doi-asserted-by":"crossref","first-page":"vii5","DOI":"10.1093\/jac\/dky156","article-title":"Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011\u201315","volume":"73","author":"JA Karlowsky","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"pone.0240655.ref007","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/jac\/dkw018","article-title":"Non-susceptibility of Escherichia coli, Klebsiella spp., Pseudomonas spp., Streptococcus pneumoniae and Staphylococcus aureus in the UK: temporal trends in England, Northern Ireland, Scotland and Wales","volume":"71","author":"R Guy","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"pone.0240655.ref008","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315","volume":"6","author":"B Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"Suppl 5","key":"pone.0240655.ref009","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/1469-0691.12461","article-title":"Pneumococcal infection in adults: burden of disease","volume":"20","author":"JJC Drijkoningen","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"pone.0240655.ref010","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"KL O\u2019Brien","year":"2009","journal-title":"Lancet"},{"unstructured":"The Government of Japan. National Action Plan on Antimicrobial Resistance (AMR) 2016\u20132020. 2016. https:\/\/www.mhlw.go.jp\/file\/06-Seisakujouhou-10900000-Kenkoukyoku\/0000138942.pdf.","key":"pone.0240655.ref011"},{"key":"pone.0240655.ref012","volume-title":"Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria","author":"Clinical and Laboratory Standars Institute","year":"2015","edition":"3"},{"volume-title":"Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement M100-S18","year":"2008","author":"Clinical and Laboratory Standards Institute","key":"pone.0240655.ref013"},{"unstructured":"AMR Clinical Reference Center. One Health Platform. [cited 3 Jun 2020]. https:\/\/amr-onehealth-platform.ncgm.go.jp\/.","key":"pone.0240655.ref014"},{"key":"pone.0240655.ref015","doi-asserted-by":"crossref","first-page":"v36","DOI":"10.1093\/jac\/dky068","article-title":"Results from the Survey of Antibiotic Resistance (SOAR) 2014\u201316 in Greece","volume":"73","author":"D Torumkuney","year":"2018","journal-title":"J Antimicrob Chemother"},{"unstructured":"European Committee on Antimicrobial Susceptibility Testing. EUCAST: Clinical breakpoints and dosing of antibiotics. [cited 25 Jun 2020]. https:\/\/www.eucast.org\/clinical_breakpoints\/.","key":"pone.0240655.ref016"},{"unstructured":"Kahlmeter G, the EUCAST Steering Committee. Redefining susceptibility testing categories S, I and R. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/EUCAST_Presentations\/2018\/EUCAST_-_Intermediate_category_-_information_for_all.pdf.","key":"pone.0240655.ref017"},{"key":"pone.0240655.ref018","doi-asserted-by":"crossref","first-page":"i63","DOI":"10.1093\/jac\/dkw068","article-title":"Results from the Survey of Antibiotic Resistance (SOAR) 2011\u201313 in Ukraine","volume":"71","author":"Y Feshchenko","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"pone.0240655.ref019","doi-asserted-by":"crossref","first-page":"i33","DOI":"10.1093\/jac\/dkw065","article-title":"Results from the Survey of Antibiotic Resistance (SOAR) 2009\u201311 and 2013\u201314 in China","volume":"71","author":"F Hu","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"pone.0240655.ref020","doi-asserted-by":"crossref","first-page":"i45","DOI":"10.1093\/jac\/dkw064","article-title":"Results from the Survey of Antibiotic Resistance (SOAR) 2011\u201313 in the Gulf States","volume":"71","author":"A Jamsheer","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"pone.0240655.ref021","doi-asserted-by":"crossref","first-page":"i21","DOI":"10.1093\/jac\/dkw070","article-title":"Results from the Survey of Antibiotic Resistance (SOAR) 2011\u201314 in the Democratic Republic of Congo, Ivory Coast, Republic of Senegal and Kenya","volume":"71","author":"A Kacou-Ndouba","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"pone.0240655.ref022","doi-asserted-by":"crossref","first-page":"i71","DOI":"10.1093\/jac\/dkw075","article-title":"Results from the Survey of Antibiotic Resistance (SOAR) 2011\u201313 in Turkey","volume":"71","author":"G Soyletir","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"pone.0240655.ref023","doi-asserted-by":"crossref","first-page":"i93","DOI":"10.1093\/jac\/dkw069","article-title":"Results from the Survey of Antibiotic Resistance (SOAR) 2009\u201311 in Vietnam","volume":"71","author":"PH Van","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"pone.0240655.ref024","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkw073","article-title":"Results from the Survey of Antibiotic Resistance (SOAR) 2012\u201314 in Thailand, India, South Korea and Singapore","volume":"71","author":"D Torumkuney","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"pone.0240655.ref025","doi-asserted-by":"crossref","first-page":"i103","DOI":"10.1093\/jac\/dkw076","article-title":"Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002\u201315","volume":"71","author":"A Zafar","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"pone.0240655.ref026","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1086\/497594","article-title":"Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?","volume":"42","author":"LR Peterson","year":"2006","journal-title":"Clin Infect Dis"},{"key":"pone.0240655.ref027","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1517\/14656566.9.2.229","article-title":"Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia","volume":"9","author":"J Aspa","year":"2008","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"pone.0240655.ref028","doi-asserted-by":"crossref","first-page":"c2096","DOI":"10.1136\/bmj.c2096","article-title":"Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis","volume":"340","author":"C Costelloe","year":"2010","journal-title":"BMJ"},{"key":"pone.0240655.ref029","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/jac\/dky031","article-title":"Association between use of different antibiotics and trimethoprim resistance: going beyond the obvious crude association","volume":"73","author":"KB Pouwels","year":"2018","journal-title":"J Antimicrob Chemother"},{"unstructured":"Centers for Disease Control and Prevention. Pneumococcal Disease: Clinical Diagnosis and Medical Management. 26 Nov 2019 [cited 8 Jun 2020]. https:\/\/www.cdc.gov\/pneumococcal\/clinicians\/diagnosis-medical-mgmt.html.","key":"pone.0240655.ref030"},{"unstructured":"National Institute for Health and Care Excellence. Recommendations: Pneumonia (community-acquired): antimicrobial prescribing Guidance. NICE; 2019 [cited 8 Jun 2020]. https:\/\/www.nice.org.uk\/guidance\/ng138\/chapter\/recommendations#choice-of-antibiotic.","key":"pone.0240655.ref031"},{"key":"pone.0240655.ref032","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jiac.2015.12.019","article-title":"JAID\/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases\/Japanese Society of Chemotherapy\u2014The JAID\/JSC Guide to Clinical Management of Infectious Disease\/Guideline-preparing Committee Respiratory Infectious Disease WG","volume":"22","author":"K Mikasa","year":"2016","journal-title":"Journal of Infection and Chemotherapy"},{"key":"pone.0240655.ref033","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jhin.2018.10.005","article-title":"Automated detection of outbreaks of antimicrobial-resistant bacteria in Japan","volume":"102","author":"A Tsutsui","year":"2019","journal-title":"Journal of Hospital Infection"},{"key":"pone.0240655.ref034","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1186\/s12913-018-3604-x","article-title":"Japan nosocomial infections surveillance (JANIS): a model of sustainable national antimicrobial resistance surveillance based on hospital diagnostic microbiology laboratories","volume":"18","author":"A Tsutsui","year":"2018","journal-title":"BMC Health Services Research"},{"unstructured":"Norweigian Institute of Public Health. ATC\/DDD Index. [cited 8 Jun 2020]. https:\/\/www.whocc.no\/atc_ddd_index\/.","key":"pone.0240655.ref035"},{"volume-title":"R: A Language and Environment for Statistical Computing","year":"2018","author":"R Core Team","key":"pone.0240655.ref036"},{"key":"pone.0240655.ref037","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jac\/49.3.433","article-title":"The in vivo\u2014in vitro paradox in pneumococcal respiratory tract infections","volume":"49","author":"W Bishai","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"pone.0240655.ref038","first-page":"470","article-title":"Severe pneumococcal pneumonia: new strategies for management","volume":"12","author":"CCC Chiou","year":"2006","journal-title":"Curr Opin Crit Care"},{"key":"pone.0240655.ref039","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/jac\/dkp209","article-title":"Antimicrobial susceptibility of Streptococcus pneumoniae at a university hospital in Taiwan, 2000\u201307: impact of modified non-meningeal penicillin breakpoints in CLSI M100-S18","volume":"64","author":"L-H Su","year":"2009","journal-title":"Journal of Antimicrobial Chemotherapy"},{"unstructured":"Ministry of Health Labour and Welfare Japan. Revision of Medical Fees. 2012. https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/iryouhoken\/iryouhoken15\/index.html.","key":"pone.0240655.ref040"},{"key":"pone.0240655.ref041","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jiac.2018.01.003","article-title":"Trends and patterns of national antimicrobial consumption in Japan from 2004 to 2016","volume":"24","author":"A Tsutsui","year":"2018","journal-title":"J Infect Chemother"},{"key":"pone.0240655.ref042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223835","article-title":"Longitudinal trends of and factors associated with inappropriate antibiotic prescribing for non-bacterial acute respiratory tract infection in Japan: A retrospective claims database study, 2012\u20132017","volume":"14","author":"Y Kimura","year":"2019","journal-title":"PLoS One"},{"key":"pone.0240655.ref043","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12913-020-5021-1","article-title":"Cost of inappropriate antimicrobial use for upper respiratory infection in Japan","volume":"20","author":"S Tsuzuki","year":"2020","journal-title":"BMC Health Services Research"},{"key":"pone.0240655.ref044","doi-asserted-by":"crossref","first-page":"e0221133","DOI":"10.1371\/journal.pone.0221133","article-title":"Seasonality of antimicrobial resistance rates in respiratory bacteria: A systematic review and meta-analysis","volume":"14","author":"EP Martinez","year":"2019","journal-title":"PLOS ONE"},{"key":"pone.0240655.ref045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1086\/323674","article-title":"Geographic, Demographic, and Seasonal Differences in Penicillin-Resistant Streptococcus pneumoniae in Baltimore","volume":"34","author":"BA Albanese","year":"2002","journal-title":"Clin Infect Dis"},{"key":"pone.0240655.ref046","doi-asserted-by":"crossref","first-page":"e861","DOI":"10.1016\/S2214-109X(19)30071-3","article-title":"Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries","volume":"7","author":"Y Hsia","year":"2019","journal-title":"The Lancet Global Health"},{"key":"pone.0240655.ref047","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1473-3099(17)30724-7","article-title":"Classifying antibiotics in the WHO Essential Medicines List for optimal use\u2014be AWaRe","volume":"18","author":"M Sharland","year":"2018","journal-title":"The Lancet Infectious Diseases"},{"key":"pone.0240655.ref048","doi-asserted-by":"crossref","first-page":"ii36","DOI":"10.1093\/jac\/dkx500","article-title":"Potential for reducing inappropriate antibiotic prescribing in English primary care","volume":"73","author":"T Smieszek","year":"2018","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"pone.0240655.ref049","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/jac\/46.4.557","article-title":"Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: the impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics","volume":"46","author":"F Marco","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"pone.0240655.ref050","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1128\/AAC.02239-13","article-title":"Trends and Seasonal Variation in Outpatient Antibiotic Prescription Rates in the United States, 2006 to 2010","volume":"58","author":"KJ Suda","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"pone.0240655.ref051","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/AAC.43.2.357","article-title":"Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996\u20131997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens","volume":"43","author":"F Baquero","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0240655.ref052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-60444-1","article-title":"Factors associated with sufficient knowledge of antibiotics and antimicrobial resistance in the Japanese general population","volume":"10","author":"S Tsuzuki","year":"2020","journal-title":"Scientific Reports"},{"key":"pone.0240655.ref053","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12916-020-01576-z","article-title":"Raising awareness of antimicrobial resistance: comment on \u201cReducing expectations for antibiotics in primary care: a randomised experiment to test the response to fear based messages about antimicrobial resistance\u201d","volume":"18","author":"Y Gu","year":"2020","journal-title":"BMC Med"},{"key":"pone.0240655.ref054","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/s12913-020-05288-1","article-title":"Impact of antimicrobial stewardship fee on prescribing for Japanese pediatric patients with upper respiratory infections","volume":"20","author":"Y Muraki","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"pone.0240655.ref055","doi-asserted-by":"crossref","first-page":"e0207017","DOI":"10.1371\/journal.pone.0207017","article-title":"Public knowledge and perception about antimicrobials and antimicrobial resistance in Japan: A national questionnaire survey in 2017","volume":"13","author":"K Kamata","year":"2018","journal-title":"PLOS ONE"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0240655","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T17:34:13Z","timestamp":1603388053000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0240655"}},"subtitle":[],"editor":[{"given":"Shampa","family":"Anupurba","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":55,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0240655","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,10,22]]}}}